Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)Agnieszka Pluta, Agnieszka Wierzbowska, Piotr Stelmach et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 3
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra-Tybor, Krzysztof Jamroziak, Aleksandra Gołoś et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 2
Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)Agnieszka Pluta, Agnieszka Wierzbowska, Kamil Brzozowski et al.|Blood|2016Cited by 1
Wyniki leczenia chorych na wtórną do chemio- i/lub radioterapii ostrą białaczkę szpikową – retrospektywne, wieloośrodkowe badanie Polskiej Grupy ds. Leczenia Białaczek u DorosłychSebastian Grosicki, Beata Piątkowska‐Jakubas, Ewa Bodzenta et al.|Acta Haematologica Polonica|2015Cited by 0
Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra‐Tybor, Krzysztof Jamroziak, Aleksandra Gołoś et al.|Blood|2019Cited by 0